BSX : WATCHMAN FLX Device Reduces Bleeding Risk, Matches Stroke Prevention After Cardiac Ablation
Boston Scientific Corp. (BSX) announced positive three-year primary endpoint results from the OPTION global clinical trial of the ...
Le Lézard5h
Pan-Mass Challenge Raises Record $75 Million for Dana-Farber Cancer Institute
The Pan-Mass Challenge (PMC), the world's single most successful athletic fundraiser, has announced a $75 million gift for ...
Le Lézard9h
NYU Langone Heart's Leading Cardiologists Present Latest Research at the American Heart Association's Scientific Sessions 2024
Experts from NYU Langone Heart will present the latest advancements in cardiovascular science and clinical care at the 2024 American Heart Association's Scientific Sessions, held from November 16 to ...
MedPage Today on MSN10h
JAK Inhibitor Succeeds in Giant Cell Arteritis Trial
WASHINGTON -- Giant cell arteritis (GCA) can be successfully treated with the oral Janus kinase (JAK) inhibitor upadacitinib ...